Literature DB >> 16502635

[Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters].

A González1, Y Rodríguez, N Batista, Y Valdés, J F Núñez, M Mirabal, M González.   

Abstract

Leptospira serogroup Ballum is at present the first cause of human leptospirosis in Cuba. Killed whole-cell vaccines were formulated with two clinical isolates of Leptospira interrogans serogroup Ballum using aluminum hydroxide as adjuvant. Agglutinins levels induced by each vaccine in hamsters were estimated by microscopic agglutination test and specific IgG activities were quantified by a whole cell-based enzyme-linked immunosorbent assay. Homologous and cross protective capacity against lethal and sublethal infection were determined in vaccinated animals by challenge with 100 and 10,000 LD50 of five virulent strains belonging to serogroups Ballum, Canicola, Icterohaemorrhagiae and Pomona. Both monovalent serogroup Ballum vaccines were immunogenic and induced complete homologous protection in the animal model. Cross-protection was only significant in one of the two vaccines against challenge with 100 LD50 of serogroup Canicola. The results of this study demonstrate the high immunogenicity and protective capacity in hamsters of whole-cell monovalent vaccines formulated with two vaccine candidate strains belonging to the most prevalent serogroup of Leptospira in Cuba.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16502635

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  4 in total

Review 1.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.

Authors:  Albert I Ko; Cyrille Goarant; Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

2.  Preliminary characterization of Mus musculus-derived pathogenic strains of Leptospira borgpetersenii serogroup Ballum in a hamster model.

Authors:  Everton F da Silva; Samuel R Félix; Gustavo M Cerqueira; Michel Q Fagundes; Amilton C P S Neto; André A Grassmann; Marta G Amaral; Tiago Gallina; Odir A Dellagostin
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

3.  Cross-protection between experimental anti-leptospirosis bacterins.

Authors:  Cristina Corsi Dib; Amane Paldês Gonçales; Zenaide Maria de Morais; Gisele Oliveira de Souza; Fabiana Miraglia; Patricia Antonia Estima Abreu; Silvio Arruda Vasconcellos
Journal:  Braz J Microbiol       Date:  2014-10-09       Impact factor: 2.476

4.  Presence of Leptospira spp. and absence of Bartonella spp. in urban rodents of Buenos Aires province, Argentina.

Authors:  Bruno Fitte; Michael Kosoy
Journal:  Pathog Glob Health       Date:  2021-08-02       Impact factor: 3.735

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.